Our researchers are fighting the coronavirus pandemic with innovative approaches. With your donation you can support them in developing drugs and vaccines against the virus or in deciphering the mechanisms of disease development and progression. Here you can find out all about donation opportunities.
Learn more about how the HZI, with its translational focus, will help to facilitate a faster and more targeted approach when it comes to fighting and preventing existing, emerging or recurring infectious diseases.
Here you can find out more about the scientific results of the HZI in the research topics ”Bacterial and Viral Pathogens”, “Immune Response and Interventions” and “Anti-Infectives”.
Around 900 employees in research, administration and infrastructure, and about 220 visiting scientists from 40 different countries are employed at the Helmholtz Centre for Infection Research. To ensure top quality research we need top quality employees. Your creativity and innovative capabilities are the basis for the long-term success of our work. That's why we undertake a great deal to attract the best people to us. Learn more about this.
We communicate also through social media. Join our Facebook page, follow us on Twitter or subscribe to our YouTube-Channel.
The coronaviruses are a family of viruses that includes a series of very different pathogens. These viruses usually infect mammals, rodents, and birds, but only few coronaviruses adapted to humans. They did this with great success: About one third of all typical "common colds" and some cases of diarrhoea as well are caused by these RNA Viruses, which are the largest of their kind. We have compiled more information about the coronaviruses for you.
With the pathogen SARS-CoV-2, a novel virus that can cause respiratory diseases and pneumonia has been spreading worldwide since the end of 2019. Here we will keep you informed about current developments in research and provide answers to the most important questions.
HomeNews & EventsNews
Results 1 to 10 of total 493
2022-01-17
HZI research team develops novel corona and flu vaccination based on cytomegalovirus
2022-01-10
Prestigious ERC Starting Grant awarded to HIRI
2021-12-14
Saarbrücken researchers develop drug candidates against hospital germs
HIRI and University of Cambridge shed light onto an essential protein-assisted genetic switch in Cardioviruses
2021-12-13
TU Braunschweig and HZI analyzed serum samples from vaccinated individuals with new corona variant
2021-12-10
HZI and HIRI study investigates antiviral protein of the immune defence system
2021-12-09
HIPS citizen science campaign boards the „MS Wissenschaft“
2021-12-08
Nationwide antibody study “MuSPAD”of the HZI investigated the differences of the first three pandemic waves in seven regions of Germany
2021-12-03
The renowned prize for young scientists goes to HZI researcher in the anniversary year of the MTZ®foundation
Statins do not increase infectivity or viral replication of SARS-CoV-2
